title: [Laser therapy of penile carcinoma].
abstract: The conventional treatment for superficial penile cancer is amputation of the penis. In contrast, the use of the neodymium-YAG laser yields better survival rates without mutilation. In a long-term follow-up (7 years) we found a survival rate of 95%. There may be an additional advantage in combined use of the laser in the treatment of advanced cases of penile cancer. We conclude that the neodymium-YAG laser should be used as first-line therapy.
authors.affiliation: Urologische Klinik, Klinikum Landshut, Ludwig-Maximilians-Universität München.
authors.forename: K H
authors.initials: KH
authors.lastname: Rothenberger
authors.forename: A
authors.initials: A
authors.lastname: Hofstetter
mesh_terms: D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D010412:Penile Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D012086:Reoperation; D015996:Survival Rate
vernacular_title: Lasertherapie des Peniskarzinoms.